Healthy Skepticism Library item: 6568

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Lexchin J.
Re: the promotion of Parlodel (bromocriptine)
1995 Jan;

Abstract:

The subsidiary of Sandoz in Pakistan is marketing Parlodel (bromocriptine) for the suppression of established lactation. The scientific literature suggests that Parlodel is no better than conservative measures and that it is associated with serious side effects.

Keywords:
*analysis/Pakistan/Canada/United States/developing countries/Parlodel/Sandoz/lactation suppression/quality of information/safety & risk information/Medical Lobby for Appropriate Marketing/MaLAM/ Health Research Group/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: BREAST FEEDING AND CONTRACEPTION